1-Benzyl 4-tert-butyl 5-methyl-1,4-diazepane-1,4-dicarboxylate

Catalog No. :
ACNGRD271
CAS No. :
1030377-24-2
Molecular Formula :
C19H28N2O4
Molecular Weight :
348.44

IUPAC Name:1-benzyl 4-(tert-butyl) 5-methyl-1,4-diazepane-1,4-dicarboxylate

1-Benzyl 4-tert-butyl 5-methyl-1,4-diazepane-1,4-dicarboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg97%$273.00Login to see priceInquiryInquiry
1g97%$683.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-Benzyl 4-tert-butyl 5-methyl-1,4-diazepane-1,4-dicarboxylate
IUPAC Name1-benzyl 4-(tert-butyl) 5-methyl-1,4-diazepane-1,4-dicarboxylate
MDL No.MFCD22419980
Molecular FormulaC19H28N2O4
Molecular Weight348.44
SMILESO=C(N1CCN(C(OC(C)(C)C)=O)C(C)CC1)OCC2=CC=CC=C2
InChI KeyXLSSEJRFMLKZQO-UHFFFAOYSA-N
Synonymtetrahydro-5-methyl-,1H-1,4-diazepine-1,4(5H)-dicarboxylic acid 4-(1,1-dimethylethyl)1-(phenylmethyl)ester;1H-1,4-Diazepine-1,4(5H)-dicarboxylic acid, tetrahydro-5-methyl-, 4-(1,1-dimethylethyl) 1-(phenylmethyl) ester
CAS No.1030377-24-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACNGRD271 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACNGRD271 route product structure diagram
    ACNGRD2711030377-24-2
Inquiry

2. ACNGRD271 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACATDJ208 route compound structure diagram
    ACATDJ208935843-93-9 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACNGRD271 route product structure diagram
    ACNGRD2711030377-24-2
Inquiry

Comments (0)